Copernicus Therapeutics, Inc. announced that it received a milestone payment from Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), a non-profit affiliate of the Cystic Fibrosis Foundation. This milestone payment is part of a research, development, and commercialization agreement between CFFT a
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Crohn's is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea.The team found that a bacterium called Mycobacterium paratuberculosis releases a molecule that prevents a type of white blood cell from killing E.coli
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Nearly three out of four patients with ulcerative colitis (UC) consider feeling unwell to be a normal part of life, while gastroenterologists estimate this to be true for only 37 percent of their UC patients, according to results from a nationwide series of surveys presented at the 2007 Crohn's & C
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Callisto Pharmaceuticals, Inc. (AMEX: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal diseases, announced that Dr. Kunwar Shailubhai, Sr. VP Discovery Research, will give an oral presentation covering preclinical data on Guanilib at the Crohn's an
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Dyslexia marked by poor reading fluency -- slow and choppy reading -- may be caused by disorganized, meandering tracts of nerve fibers in the brain, according to researchers at Children's Hospital Boston and Beth Israel Deaconess Medical Center (BIDMC). The study, using the latest imaging methods,
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Some people who have problems reading quickly appear to have abnormalities in the white matter of their brains, according to research published in the December 4, 2007, issue of Neurology®, the medical journal of the American Academy of Neurology. Researchers say these findings provide a model to b
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Treatment with ibuprofen is associated with a significantly slower rate of decline in lung function in children and adolescents with cystic fibrosis, according to a new study. Researchers found that patients with cystic fibrosis (CF) who took high doses of ibuprofen had a 29 percent reduction in lo
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Galapagos NV (Euronext & LSE: GLPG) and Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT), the non-profit affiliate of the Cystic Fibrosis Foundation, have announced a new collaboration aimed at discovering new treatments for cystic fibrosis. This new agreement between CFFT and Galapagos' BioFoc
read more »
Source:http://www.medicalnewstoday.com DiscussBury
A specific variation in the glucocorticoid receptor gene is associated with lung disease progression in cystic fibrosis, research published this week in the online open access journal Respiratory Research reveals. This finding adds weight to previous research suggesting that specific subgro
read more »
Source:http://www.medicalnewstoday.com DiscussBury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.